Poultry<strong>Georgia</strong>’s poultry industry dominated the state’s animal agricultural dollars withmore than $2.5 billion in annual revenue in 1996. The state’s poultry industry iscontinuing to expand as broiler production in <strong>Georgia</strong> increased from 20.6million per week in 1995 to 22.2 million per week in 1996. The urbanization <strong>of</strong>northern <strong>Georgia</strong> is causing the broiler expansion to occur primarily in the state’ssouthern section. Because <strong>of</strong> the intensive management system, poultryproducers emphasize disease prevention. VMES scientists have responded toindustry demands by developing vaccines to prevent infectious diseases. Theyare also helping to improve poultry health by developing inexpensive, rapid, andaccurate methods for disease diagnosis. Although the primary poultry healthconcerns are respiratory diseases, recent efforts have been initiated to controltype J avian leukosis virus, a major cause <strong>of</strong> the tumor, myeloblastosis.Researchers are also focusing on the reduction <strong>of</strong> potential human pathogens onpoultry products nationwide.Increasing Resistance to Marek’s Diseasevia Immune ModulationDiagnostics for Avian Enteric CoronavirusInfections in Commercial Poultry6The overall objectives <strong>of</strong> this project are toestablish the importance <strong>of</strong> natural killer (NK)cell-like activity in the innate ability <strong>of</strong> chickensto resist Marek’s disease virus (MDV)infection and to then determine whether modulation<strong>of</strong> this natural immunity (NK cell activity)could be used as part <strong>of</strong> Marek’s diseaseprevention programs.We have assessed NK-like activity <strong>of</strong>chickens having haplotypes reported to confereither resistance, N-2a chickens (B13), or sensitivity,P-2a chickens (B21), to MDV. Theresults from cytotoxicity assays indicate N-2achickens have greater killing capabilities byNK cells than the P-2a chickens. The N-2achickens displayed greater killing at one, two,and three weeks <strong>of</strong> age, with the increasebecoming significant by the third week. Wehave also compared NK activities in two commerciallines <strong>of</strong> broilers: Arbor Acres line andPerdue line. Between these two broiler lineswe found the Perdue birds to have significantlyhigher natural cytotoxic ability. Studies wereperformed to assess the efficacy <strong>of</strong> possibleimmune modulators on susceptibility toMarek’s disease. NK cell activity was assayedat day 7 postvirus challenge (day 14 postmodulation).Surviving birds were euthanized, andnecropsy with histopathology was performedat six weeks for determination <strong>of</strong> disease susceptibility,organ involvement, and severity <strong>of</strong>disease. In the broiler line (Arbor Acres), theimmunomodulator significantly increased theNK-like cytotoxic activity. Comparison <strong>of</strong>immunomodulated birds with birds thatreceived only virus suggests that theimmunomodulator may be a protective factoragainst Marek’s disease in this broiler line.Denise I. Bounous, Steven E. Poet, William L.Ragland, Mark A. Goodwindbounous@calc.vet.uga.eduVirus neutralizing polyclonal antibodieswere developed in rabbits using multipleimmunizations <strong>of</strong> adjuvant plus purified cellculture-origin sucrose gradient purified avianenteric coronavirus (AEC). The antibodieswere used to develop 1) an indirect immun<strong>of</strong>luorescentantibody detection system (IFA)for either AEC or anti-AEC antibody afterinfection; 2) fluorescent detection <strong>of</strong> AEC infrozen tissue sections; and 3) immunohistochemicaldetection <strong>of</strong> AEC in formalin-fixedtissue sections. The IFA system was adapted to96 well microtiter plates to increase throughput.The latter antibody technique is currentlybeing used as part <strong>of</strong> the eradication plan todetect flocks naturally infected with AEC, sothey can be eliminated to prevent spread toother poultry farms. Bovine enteric coronaviruswas found to infect commercial turkeys.Infection <strong>of</strong> poultry with this virus leads toconfusion in AEC eradication programs. Wehave developed seven monoclonal antibodies(Mabs) against AEC surface proteins. TheseMabs are being used in the IFA test to differentiateAEC infection from bovine coronavirus(BCV) infection in cell cultures and birds.Genes coding for the S surface viral protein<strong>of</strong> multiple AEC isolates have beensequenced and primer sets constructed to identifythese genes. Polymerase chain reaction(PCR) assays have been developed based onthese primers. These PCR primers and additionalprimer sets are currently being investigatedfor in situ use as probes for AEC. Inaddition, sequences coding for AEC viral proteinS are being cloned into vectors for production<strong>of</strong> vaccinal quantities <strong>of</strong> this viral proteinfor test immunization.Thomas P. Brown, Doris D’Souza, Laura Kelly,AnaPatricia Garciatbrown@arches.uga.edu
Differential Diagnosis <strong>of</strong> InfectiousLaryngotracheitis Viruses by PCRInfectious Laryngotracheitis is a severeacute respiratory disease <strong>of</strong> chickens caused byInfectious Laryngotracheitis Virus (ILTV), amember <strong>of</strong> the family Alphaherpesviridiae.During 1994-1995, ILT outbreaks were reportedin <strong>Georgia</strong>, Alabama, Arkansas, andDelaware. These outbreaks caused severefinancial losses to the poultry industry. Themajor obstacle against the effective control andprevention <strong>of</strong> the disease is the inability toclearly and easily determine the source <strong>of</strong> outbreaks.Therefore, discrimination <strong>of</strong> ILTVstrains <strong>of</strong> different pathogenicity, and particularly<strong>of</strong> field isolates from vaccine strains, is amajor necessity. The main objective <strong>of</strong> thisproject is to develop a polymerase chain reaction(PCR) test capable <strong>of</strong> distinguishingamong ILTV strains circulating in the field.We have identified restriction enzyme site differencesin the gE gene, and the upstreamregion <strong>of</strong> the ICP4 gene. Digestion <strong>of</strong> PCRproducts with specific enzymes, deduced fromthe sequence data obtained during this year’sproject, has allowed us to characterize fieldisolates as either “chicken embryo origin(CEO) like,” or “tissue culture origin (TCO)like” vaccine strains. Most importantly, wehave identified restriction enzymes that producerestriction fragment length polymorphism(RFLP) patterns unique to some <strong>of</strong> the fieldisolates analyzed. These indicate that specificmutations are acquired by field isolates atthese particular areas <strong>of</strong> the genome, for example,digestion <strong>of</strong> PCR products <strong>of</strong> the sevenfield isolates with enzymes DdeI, MnLI,and Ple.Maricarmen Garcíamcgarcia@arches.uga.eduprocess <strong>of</strong> producing a recombinant chickenbeta-defensin.Recombinant peptides will be used tocharacterize the complete spectrum <strong>of</strong> antimicrobialactivity against avian pathogens.Moreover, development <strong>of</strong> resistance to theseendogenous antibiotics by pathogenic bacteriacan be studied using recombinant defensins.Ultimately, it may be possible to manipulatethis endogenous defense system to enhancedisease resistance in poultry.Barry G. Harmon and Mark W. Jackwoodharmonb@calc.vet.uga.eduRecombinant Vaccines for InfectiousBronchitis VirusThe main objective <strong>of</strong> this proposal is todevelop a recombinant vaccine for infectiousbronchitis virus (IBV). A plasmid expressionvector that works in an avian cell line is beingused to express the immunogenic spike glycoprotein<strong>of</strong> IBV. The expressed protein is beingcharacterized and tested for its suitability as asubunit vaccine in chickens. In addition, anewly redesigned nucleic acid vaccine for IBV,which provides higher expression <strong>of</strong> the IBVspike glycoprotein, was tested and found to beefficacious when given to young chickens byintramuscular injection at 1 and 14 days <strong>of</strong>age. We are currently examining the immuneresponse generated by that vaccine, as well astesting for its suitability when given in ovo.Mark W. Jackwoodmjackwoo@arches.uga.eduAntimicrobial Peptides in Broiler ChickensAntimicrobial peptides are important components<strong>of</strong> innate disease resistance in vertebrateand invertebrate animals. These peptidesarm phagocytic leukocytes and mucosalepithelial cells <strong>of</strong> the gastrointestinal and respiratorytract with a broad spectrum <strong>of</strong> antimicrobialactivity and serve as the first line <strong>of</strong>defense against microbial pathogens. Recently,we discovered the cDNA sequences for twochicken and two turkey heterophil antimicrobialpeptides, referred to as betadefensins.We will now attempt to sequencethe genes that encode the avian defensins andthen study the regulation and expression <strong>of</strong>these genes. We have cloned the cDNAsequences for a chicken peptide and are in theVictoria Leiting works on DNA fingerprinting <strong>of</strong> Mycoplasma organisms.7
- Page 3 and 4: VM E S ‘98Veterinary Medical Expe
- Page 7: DNA VaccinesEver since Dr. Edward J
- Page 11 and 12: Hemolysin is one type of virulence
- Page 13 and 14: ism without the epv gene. The resul
- Page 15 and 16: Cattle and Other RuminantsCattle, s
- Page 17 and 18: The Use of in situ Hybridization to
- Page 19 and 20: Endotoxin Antagonists: Characterizi
- Page 21 and 22: WildlifeGeorgia’s wildlife habita
- Page 23 and 24: Companion AnimalsCompanion animals
- Page 25 and 26: esearch paid for by VMES funds wher
- Page 27 and 28: Research Contracts and GrantsAllen,
- Page 29 and 30: Administrators and AdvisorsThe Univ
- Page 31 and 32: Hullinger, Gordon A., DVM, PhD, Ass
- Page 33 and 34: Selected PublicationsAllen, S.W., C
- Page 35 and 36: Hay, W.P., Baskett, A., Abdy, M.J.:
- Page 37 and 38: Quist, C.F., Howerth, E.W., Bounous